Cancer Vaccine: 4 Months of Life Worth $100K?

By Yahoo! News Search Results for prostate cancer | July 29, 2010

Prostate cancer vaccine, Provenge, adds 4 months to life, at a pricetag of $100K. Prostate cancer - Sipuleucel-T - Cancer - Cancer vaccine - Health

Topics: Uncategorized | No Comments »

Dense Bones Linked To Raised Risk For Prostate Cancer

By Yahoo! News Search Results for prostate cancer | July 29, 2010

Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health. The finding, published in the July British Journal of Urology International ...

Topics: Uncategorized | No Comments »

Low-risk prostate cancer treated aggressively

By Yahoo! News Search Results for prostate cancer | July 29, 2010

Many men with low-risk prostate cancer get aggressive treatment, increasing the risk of serious side effects, U.S. researchers said on Monday.

Topics: Uncategorized | No Comments »

Low-risk prostate gets aggressive therapy

By Yahoo! News Search Results for prostate cancer | July 29, 2010

NEW BRUNSWICK, N.J., July 29 (UPI) -- Most men treated for prostate cancer, even if their prostate-specific antigen level and cancer risk are low, receive aggressive treatment, U.S. researchers say. Cancer - Prostate cancer - Health - Conditions and Diseases - Genitourinary

Topics: Uncategorized | No Comments »

Dense bones associated with raised risk for prostate cancer

By Yahoo! News Search Results for prostate cancer | July 29, 2010

Washington, July 29 : A new study has found that men, who develop prostate cancer, tend to retain denser bones as they age than men who stay free of the disease.

Topics: Uncategorized | No Comments »

Aggressive prostate cancer tend to retain denser bones

By Yahoo! News Search Results for prostate cancer | July 29, 2010

Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health.

Topics: Uncategorized | No Comments »

Dense bones linked to raised risk for prostate cancer

By Yahoo! News Search Results for prostate cancer | July 29, 2010

Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research.

Topics: Uncategorized | No Comments »

Dendreon’s Prostate Cancer Drug Extends Life in Published Study

By Yahoo! News Search Results for prostate cancer | July 28, 2010

Dendreon Corp.’s prostate cancer vaccine, Provenge, extended lives by 4.1 months in a study published in the New England Journal of Medicine. The data, released previously, led to the drug’s U.S. approval in April.

Topics: Uncategorized | No Comments »

Dense bones linked to raised risk for prostate cancer

By Yahoo! News Search Results for prostate cancer | July 28, 2010

( Johns Hopkins Medical Institutions ) Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging, part of the National Institutes of Health.

Topics: Uncategorized | No Comments »

Prostate screening, overdiagnosis linked

By Yahoo! News Search Results for prostate cancer | July 28, 2010

While early detection and treatment has improved the survival rate in prostate cancer sufferers, it has led to potential overdiagnosis and overtreatment.

Topics: Uncategorized | No Comments »

« Previous Entries